Tango Therapeutics, Inc. (TNGX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$16.16
Day's range
$16.95

Tango Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 05/15/2026 13.30 M $278.25 M   791.92% 11.45%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 12.81 M $267.97 M   20.75% 11.03%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 10.88 M $227.53 M   0.00% 9.36%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 10.53 M $220.31 M   -17.48% 9.07%
FMR LLC 05/15/2026 9.91 M $207.23 M   245.45% 8.53%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 9.10 M $190.32 M   -30.35% 7.83%
BLACKROCK, INC. 05/13/2026 8.75 M $183.01 M   2.43% 7.53%
WOODLINE PARTNERS LP 05/15/2026 8.00 M $167.36 M   -20.57% 6.89%
NEXTECH INVEST, LTD. 05/15/2026 7.27 M $152.01 M   0.00% 6.25%
TRV GP IV, LLC 05/07/2026 6.37 M $133.36 M   -19.05% 5.49%
SIREN, L.L.C. 05/14/2026 5.66 M $118.35 M   -30.72% 4.87%
05/15/2026 5.16 M $107.98 M   100.00% 4.44%
GOLDMAN SACHS GROUP INC 05/15/2026 5.08 M $106.20 M   2.71% 4.37%
STATE STREET CORP 05/15/2026 4.65 M $97.32 M   -25.19% 4.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 05/15/2026 4.15 M $86.75 M   42.65% 3.57%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2026 4.01 M $83.88 M   100.00% 3.45%
HOLOCENE ADVISORS, LP 05/15/2026 3.93 M $82.27 M   100.00% 3.39%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 3.83 M $80.05 M   -27.51% 3.29%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 3.00 M $62.76 M   -28.57% 2.58%
DEEP TRACK CAPITAL, LP 05/15/2026 2.75 M $57.53 M   12.04% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.68 M $55.99 M   4.78% 2.30%
CALIGAN PARTNERS LP 05/15/2026 2.41 M $50.39 M   -35.42% 2.07%
BELLEVUE GROUP AG 05/15/2026 2.40 M $50.21 M   -38.90% 2.07%
JANUS HENDERSON GROUP PLC 05/18/2026 2.39 M $50.07 M   -9.43% 2.06%
VIVO CAPITAL, LLC 05/20/2026 2.15 M $45.08 M   0.00% 1.85%
MORGAN STANLEY 05/15/2026 1.48 M $30.91 M   3.92% 1.27%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 1.43 M $29.81 M   100.00% 1.23%
FRANKLIN RESOURCES INC 05/13/2026 1.30 M $27.12 M   -7.28% 1.12%
CANDRIAM S.C.A. 04/30/2026 1.27 M $26.55 M   79.07% 1.09%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 1.25 M $26.16 M   -65.00% 1.08%
05/08/2026 901.47 K $18.86 M   100.00% 0.78%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 889.40 K $18.61 M   1,422.06% 0.77%
NORTHERN TRUST CORP 05/14/2026 862.94 K $18.05 M   7.44% 0.74%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 838.68 K $17.55 M   -0.28% 0.72%
PERCEPTIVE ADVISORS LLC 05/29/2026 808.15 K $16.91 M   57.52% 0.70%
BESSEMER GROUP INC 05/06/2026 708.40 K $14.82 M   0.00% 0.61%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2026 708.39 K $14.82 M   0.00% 0.61%
UBS GROUP AG 05/05/2026 699.35 K $14.63 M   -29.39% 0.60%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 662.92 K $13.87 M   100.00% 0.57%
INVESCO LTD. 05/12/2026 580.45 K $12.14 M   226.81% 0.50%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 571.35 K $11.95 M   -40.32% 0.49%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 533.94 K $11.17 M   -72.95% 0.46%
AMERIPRISE FINANCIAL INC 05/15/2026 506.16 K $10.59 M   100.00% 0.44%
06/04/2026 502.01 K $10.50 M   133.31% 0.43%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 489.35 K $10.24 M   0.47% 0.42%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 450.00 K $9.41 M   125.00% 0.39%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 450.00 K $9.41 M   4,400.00% 0.39%
ACUTA CAPITAL PARTNERS, LLC 05/15/2026 441.83 K $9.24 M   56.27% 0.38%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 05/15/2026 440.02 K $9.21 M   -1.39% 0.38%
MILLENNIUM MANAGEMENT LLC 05/15/2026 425.64 K $8.90 M   -28.22% 0.37%

Tango Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 233 institutional investors and hedge funds held shares of Tango Therapeutics Inc. The most heavily invested institutionals were:

RTW INVESTMENTS, LP: 13.3 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 12.81 M

Boxer Capital Management, LLC: 10.88 M

TCG Crossover Management, LLC: 10.53 M

FMR LLC: 9.91 M

FARALLON CAPITAL MANAGEMENT LLC: 9.1 M

155.17% of Tango Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 198.50 M shares in the last 24 months. This purchase volume represents approximately $3.27 B in transactions.